跳至主要内容
临床试验/JPRN-UMIN000010056
JPRN-UMIN000010056已完成未知

Comparison of antiemetic effectiveness and safety of palonosetron and dexamethasone with palonosetron, dexamethasone and aprepitant in patients with lung cancer receiving combination therapy with carboplatin: A phase II randomized study - Comparison of effectiveness of palonosetron and dexamethasone with palonosetron, dexamethasone and aprepitant in patients with lung cancer

Hamamatsu University School of Medicine0 个研究点目标入组 80 人开始时间: 2013年3月10日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients with severe complications. Patients with brain metastasis. Patients with convulsive disorders requiring treatment. Patients with pleural effusion or ascites requiring treatment. Patients with gastrointestinal obstruction. Patients with drug sensitivities. Patients received antiemetic therapy as below, in the 24 hours before chemotherapy. 5HT3 receptor antagonist, NK1 receptor antagonist, adrenocortical steroid, antidopaminergic agent, phenothiazine derivative, antihistamine, benzodiazepine compound. Pregnant female, nursing mom.

研究者

相似试验